Role of the Fibroblast Activation Protein (FAP) as Biomarker of Fibrotic Lung Diseases

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Belgium

Medecine, Brussels